Stuttering, Developmental
11
6
6
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
9.1%
1 terminated out of 11 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (11)
Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech
Organization and Development of Motor Cortical Circuits for Speech Production in Stuttering
The Development of Stuttering in Young Children
Investigating Individual Differences in Speech Motor Skills in Neurotypical Speakers and Persons With Disordered Speech
Transcranial Alternating Current Stimulation (tACS) in Stuttering
Auditory Prediction and Error Evaluation in the Speech of Individuals Who Stutter
Exploring the Nature, Assessment and Treatment of Stuttering
TreatPaCS = Treatment for Preschool Age Children Who Stutter
Investigating Non-invasive Brain Stimulation to Enhance Fluency in People Who Stutter
Non-invasive Brain Stimulation in Adults Who Stutter
The Effect of the Non-invasive Brain Stimulation on the Speech Fluency Enhancement